Accordingly, PTN and MK are upregulated in senile plaques and sera of patients with Alzheimer’s disease (AD) and in the substantia nigra of patients with PD among other neurodegenerative disorders (Herradon and Perez-Garcia, 2014). Here, PTN is linked to Alzheimer disease.